Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjects

scientific article published in July 2002

Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjects is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/107602960200800310
P698PubMed publication ID12361204

P50authorMaria A. SardoQ43055679
P2093author name stringDomenica Altavilla
Salvatore Campo
Antonino Saitta
Maria Castaldo
Michele Bonaiuto
Antonella Maesano
Antonio Versace
Giacomo Nicocia
Maurizio Cinquegrani
Miriam Spadaro
P2860cites workRegulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise trainingQ28145799
Levels of soluble cell adhesion molecules in patients with dyslipidemiaQ28279951
The reaction of no with superoxideQ28611742
The pathogenesis of atherosclerosis: a perspective for the 1990sQ29547827
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluidsQ29616817
Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundanceQ31796937
Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects.Q32063018
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animalsQ33688733
Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthaseQ33844099
Hypercholesterolemia increases endothelial superoxide anion productionQ35610616
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokinesQ35749970
Endothelial dysfunction: does it matter? Is it reversible?Q36874825
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) studyQ40873641
Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formationQ40906263
The physiology and pathophysiology of the nitric oxide/superoxide systemQ41540463
Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemiaQ54255745
P433issue3
P407language of work or nameEnglishQ1860
P921main subjecthypercholesterolemiaQ762713
P304page(s)257-263
P577publication date2002-07-01
P1433published inClinical and Applied Thrombosis-HemostasisQ5133805
P1476titleEffects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjects
P478volume8

Reverse relations

cites work (P2860)
Q24202363Lipid lowering efficacy of atorvastatin
Q24187301Lipid-lowering efficacy of atorvastatin
Q36768488Statins as first-line therapy for acute coronary syndrome?
Q37276466Statins in the first-line therapy of acute coronary syndrome - similar to aspirin?

Search more.